24»þ´Ö¥¿¥¤¥à¥»¡¼¥ë
ÈþÍÆ ·ò¹¯´ØÏ¢¥é¥ó¥¥ó¥°
¿©ÉÊ´ØÏ¢¥é¥ó¥¥ó¥°
¥Õ¥¡¥Ã¥·¥ç¥ó´ØÏ¢
»Ò¶¡Éô²°¡¡¥¥Ã¥ºÍÑÉÊ
²ÈÅÅ¡¦À¸³è²ÈÅÅ
¤ª¼ò¡¦¥¢¥ë¥³¡¼¥ëÎà
²Ö¡¦DIY¡¦¸¤¡¦ÇÍÑÉÊ
¥ï¥¤¥ó¡¢¤ª¼òÎà
¥É¥ê¥ó¥¯¡¢¥³¡¼¥Ò¡¼Îà
¿©ÉÊ¡¢·ò¹¯Îà
¥«¥á¥é¡¢²ÈÅÅÎà
¥Û¡¼¥à¡õ¥¥Ã¥Á¥ó
¤ª¤â¤Á¤ã
¤Û¤·¤¤¤â¤Î¥é¥ó¥¥ó¥°
¿©ÉÊ¡õ°ûÎÁ
1000±ß
1000±ß¡Á
2000±ß¡Á
3000±ß¡Á
4000±ß¡Á
ÈþÍÆ¡¦·ò¹¯
¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä¤Î²òÀâ ¹âȿȯÆÃͤΥ½¥Õ¥È¤ÊÃÆÎϤȹ⤤Éü¸µÎϤDz÷Ŭ¤ËÁ´¿È¤ò»Ù¤¨¡¢ ¹øÄˤǤªÇº¤ß¤ÎÊý¤ä¡¢¿²¤Æ¤âÈè¤ì¤¬¤È¤ì¤Ê¤¤Êý¤Ë¤âÂ繥ɾ¤Î¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¤Ë¥¦¥¤¥ë¥¹¤òµÛÃ夷¤ÆÇ˲õ¡¢99.99¡ó¸º¾¯¤µ¤»¤ëÁ´¤¯½é¤á¤Æ¤Î¹³¥Ð¥¯¥Æ¥ê¥¢¡¦¹³¥¦¥¤¥ë¥¹¤Î¥·¥ê¡¼¥º¤¬¿·Åо졣 ¥Þ¥Ã¥È¥ì¥¹¤ä»°¤ÄÀÞ¤ê¥Þ¥Ã¥È¥ì¥¹¡¢¥Õ¥È¥ó¥¿¥¤¥×¤È¡¢Éý¹¤¤ÍÑÅӤˤ´»ÈÍѤ¤¤¿¤À¤±¤ë¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä¤¬¤Ç¤¤Þ¤·¤¿¡ª ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¤Ï²÷̲¤Ë²Ã¤¨¡¢¿²¼¼¤Î°ÂÁ´¤Ë¤â¤³¤À¤ï¤ê¤Þ¤¹¡£ ¤´¼«Ê¬¤ä¤´²È²¤Î¿²¼¼¤Î°Â¿´¤Î¤¿¤á¤Ë¤Ï¤â¤Á¤í¤ó¡¢Â£¤ê¤â¤Î¤Ë¤â¤ª¤¹¤¹¤á¤Ç¤¹¡£ ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä¤Î¾ÜºÙ ¥µ¥¤¥º ¥·¥ó¥°¥ë¡§¶Ò100x¾æ195x¸ü¤ß11¡Á27cm ¥»¥ß¥À¥Ö¥ë¡§¶Ò120x¾æ195x¸ü¤ß11¡Á27cm ¥À¥Ö¥ë¡§¶Ò140x¾æ195x¸ü¤ß11¡Á27cm ¥¯¥¤¡¼¥ó¡§¶Ò160x¾æ195x¸ü¤ß11¡Á27cm À¸ÃÏ ¥Ý¥ê¥¨¥¹¥Æ¥ë 100¡ó ¡ãHeiQ Viroblock²Ã¹©¡ä ÂçʬÎà ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¤³¤ó¤ÊÊý¤Ë ¤ª¤¹¤¹¤á ¥Ù¥Ã¥É¥Þ¥Ã¥È¥ì¥¹¤ò¤ª»È¤¤¤ÎÊý¤Ç ¡¦¥¦¥¤¥ë¥¹¤¬µ¤¤Ë¤Ê¤ëÊý ¡¦É÷¼Ù¤ò¤Ò¤¤ä¤¹¤¤Êý ¡¦²ð¸î¡¢ÎÅÍÜÃæ¤ÎÊý ¡¦¼õ¸³ÊÙ¶¯Ãæ¤ÎÊý ¡¦´À¤Î¤Ë¤ª¤¤¤¬µ¤¤Ë¤Ê¤ëÊý ¡¦¿²¶ñ¤Î±ÒÀ¸Ì̤ˤ³¤À¤ï¤ê¤Î¤¢¤ëÊý À½Â¤ÃÏ ¥¤¥¿¥ê¥¢ ¤½¤Î¾ Á÷ÎÁ̵ÎÁ¡¦Âå°ú¤¼ê¿ôÎÁ̵ÎÁ¡¦Å¹ÊÞ¼õ¼è²Ä ÅöŹ¤Ï¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¤ÎÀµµ¬ÈÎÇäŹ¡¦Ç§Äꥷ¥ç¥Ã¥×¤Ç¤¹¡£ ¼ÂŹÊޤǤ⤪»î¤·¤Ç¤¤Þ¤¹¡Ê¥Þ¥Ë¥¹¥Æ¡¼¥¸¾ÅÆî¡Ë ¢¨ ³«Éõ¸å¤ÎÊÖÉʤϤª¼õ¤±¤Ç¤¤Þ¤»¤ó¤Î¤Ç¤´Ãí°Õ¤¯¤À¤µ¤¤¡£ Êݾڤä¼è°·¤¤¤Ë¤Ä¤¤¤Æ¤Î¤´Ãí°Õ >>¥Í¥Ã¥È¤Î¤Õ¤È¤óÀìÌçŹ¡Ö¤Õ¤«¤Õ¤«¡× ¡ä ÉߤդȤó ¡ä ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ä ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡¦¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¤ª»È¤¤¤Î¥Þ¥Ã¥È¥ì¥¹¤äÉߤդȤó¤ò¥¦¥£¥ë¥¹¤«¤é¤Þ¤â¤ë¡¢¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä¤Ç¤¹¡£ Ãí1¡ËM.J. (2020) Report on "Viral Stability and Persistence of SARS-CoV-2 on Treated Material".Doherty Institute for Infection and Immunity, Australia ¥Þ¡¼¥¯¤ÎÀâÌÀ¤Ï¤³¤Á¤é>> ¡Ö´¶À÷¾ÉÂкö¤Ï¡¢°ÂÁ´¤Ë̲¤Ã¤Æ¡¢°ÂÁ´¤Ë¿©¤Ù¤Æ¡¢°ÂÁ´¤Ë»Å»ö¤ò¤¹¤ë¡£ ¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤Ï¡¢¤½¤Î¤¿¤á¤Î´ðËÜ¥¢¥¤¥Æ¥à¤È¤·¤Æ¤Þ¤¹¤Þ¤¹½ÅÍפˤʤê¤Þ¤¹¡× ¥Ï¥¤¥¥å¡¡¥ô¥£¥í¥Ö¥í¥Ã¥¯¤Ë¤Ä¤¤¤Æ¾Ü¤·¤¯¤Ï¤³¤Á¤é¤Ø >> ¡Ú¤´Ãí°Õ¡Û ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦¹³¥¦¥¤¥ë¥¹Àǽ¤ÏÁ´¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º W140¡ßD195¡ßH11¡Á27cmÍÑ ¡Ê¥À¥Ö¥ë¥µ¥¤¥º¡Ë¡¡ ¦À¸ÃÏ ¥Ý¥ê¥¨¥¹¥Æ¥ë100¡ó ¤ª¼êÆþ¤ì ¿åÀö¤¤²Äǽ ¢¨ÀöÂõ¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤¡£ ¢¨¥¿¥ó¥Ö¥é¡¼´¥Áç¤Ï¤ªÈò¤±¤¯¤À¤µ¤¤¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥¤¥¿¥ê¥¢È¯¤Î¿²¶ñÁí¹ç¥Ö¥é¥ó¥É¡Ö¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡× ¿²¼¼¤òÂ礤ʰ¿´¤ÇÊñ¤à ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥·¥ê¡¼¥º ¥¹¥¤¥¹¡¦¥Ï¥¤¥¥å¼Ò¤ÎÀèü¥Æ¥¯¥Î¥í¥¸¡¼¤òƳÆþ¤¹¤ë¤³¤È¤ÇÈó¾ï¤ËÍ¥¤ì¤¿¹³¶Ý¸ú²Ì¤ò¼Â¸½ ¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¡¢¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ç¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»ÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ Èó¾ï¤ËÍ¥¤ì¤¿¹³ÈùÀ¸Êª¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ ¦À¸ÃϤϼè¤ê³°¤·¤Æ¤ªÀöÂõ¤¬²Äǽ¤Ç¡¢HEIQ VIROBLOCKµ»½Ñ¤ò¹½À®¤¹¤ë2¤Ä¤Îµ»½Ñ¤Î¤¦¤Á¶äÀ®Ê¬¤Ï60¡î¤Î¤Ì¤ë¤ÞÅò¤Ç 50²ó¡¢¥Ù¥·¥¯¥ëµ»½Ñ¤Ï30²ó¤Î¤ªÀöÂõ¤Ç¸ú²Ì¤ò»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ 60¡î¡Á70¡îÄøÅ٤Υ¢¥¤¥í¥ó¤â²Ã¹©¤Ë±Æ¶Á¤òµÚ¤Ü¤¹¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹À½Éʤˤª¤¤¤Æ¿ÍÂΡ¢Ãϵå´Ä¶¤Ë°ìÀÚ̵³²¤Ç¤¢¤ë¤³¤È¤òǧÄꤹ¤ë¹ñºÝµ¬³Ê¡ÖOEKO-TEX¥¹¥¿¥ó¥À¡¼¥É100¡×¤ò¼èÆÀ °ÂÁ´¤ÊÁ¡°ÝÀ½ÉʤǤ¢¤ë¾Ú¥¨¥³¥Æ¥Ã¥¯¥¹¡¦¥¹¥¿¥ó¥À¡¼¥É100¤Ë²Ã¤¨¡¢¤µ¤é¤ËÊñ³çŪ¤Ê»ëÅÀ¤ÇÁ¡°ÝÀ½ÉʤòÀ¸»º¤¹¤ë¹©¾ì¤ä ´ë¶È¤¬¤¤¤«¤Ë»ý³²Äǽ¤ÊÂÎÀ©¤Ç¤¢¤ë¤«¤òɾ²Á¤¹¤ë¡Ö¥¨¥³¥Æ¥Ã¥¯¥¹STeP¡×ǧ¾Ú¤â³ÍÆÀ¤·¤Æ¤¤¤Þ¤¹¡£ ¤´Ãí°Õ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¼Àɤμ£Ìþ¤äͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¤¹¤Ù¤Æ¤Îɸ¶¶Ý¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ¡¦·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¹¡£¼ÂºÝ¤Î»ÈÍѴĶ¤Ë¤ª¤¤¤ÆƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ M.J. (2020) Report on "Viral Stability and Persistence of SARS-CoV-2 on Treated Material".Doherty Institute for Infection and Immunity, Australia¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤Ï¤¹¤Ù¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¢¨ ²èÁü¤Ï¥¤¥á¡¼¥¸¤Ç¤¹¡£¥â¥Ë¥¿¡¼¤Ë¤è¤ê¼ÂºÝ¤Î¿§Ì£¤È¿¾¯°Û¤Ê¤ë¾ì¹ç¤¬¤´¤¶¤¤¤Þ¤¹¡£
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º W160¡ßD195¡ßH11¡Á27cmÍÑ ¡Ê¥¯¥¤¡¼¥ó¥µ¥¤¥º¡Ë¡¡ ¦À¸ÃÏ ¥Ý¥ê¥¨¥¹¥Æ¥ë100¡ó ¤ª¼êÆþ¤ì ¿åÀö¤¤²Äǽ ¢¨ÀöÂõ¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤¡£ ¢¨¥¿¥ó¥Ö¥é¡¼´¥Áç¤Ï¤ªÈò¤±¤¯¤À¤µ¤¤¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥¤¥¿¥ê¥¢È¯¤Î¿²¶ñÁí¹ç¥Ö¥é¥ó¥É¡Ö¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡× ¿²¼¼¤òÂ礤ʰ¿´¤ÇÊñ¤à ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥·¥ê¡¼¥º ¥¹¥¤¥¹¡¦¥Ï¥¤¥¥å¼Ò¤ÎÀèü¥Æ¥¯¥Î¥í¥¸¡¼¤òƳÆþ¤¹¤ë¤³¤È¤ÇÈó¾ï¤ËÍ¥¤ì¤¿¹³¶Ý¸ú²Ì¤ò¼Â¸½ ¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¡¢¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ç¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»ÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ Èó¾ï¤ËÍ¥¤ì¤¿¹³ÈùÀ¸Êª¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ ¦À¸ÃϤϼè¤ê³°¤·¤Æ¤ªÀöÂõ¤¬²Äǽ¤Ç¡¢HEIQ VIROBLOCKµ»½Ñ¤ò¹½À®¤¹¤ë2¤Ä¤Îµ»½Ñ¤Î¤¦¤Á¶äÀ®Ê¬¤Ï60¡î¤Î¤Ì¤ë¤ÞÅò¤Ç 50²ó¡¢¥Ù¥·¥¯¥ëµ»½Ñ¤Ï30²ó¤Î¤ªÀöÂõ¤Ç¸ú²Ì¤ò»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ 60¡î¡Á70¡îÄøÅ٤Υ¢¥¤¥í¥ó¤â²Ã¹©¤Ë±Æ¶Á¤òµÚ¤Ü¤¹¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹À½Éʤˤª¤¤¤Æ¿ÍÂΡ¢Ãϵå´Ä¶¤Ë°ìÀÚ̵³²¤Ç¤¢¤ë¤³¤È¤òǧÄꤹ¤ë¹ñºÝµ¬³Ê¡ÖOEKO-TEX¥¹¥¿¥ó¥À¡¼¥É100¡×¤ò¼èÆÀ °ÂÁ´¤ÊÁ¡°ÝÀ½ÉʤǤ¢¤ë¾Ú¥¨¥³¥Æ¥Ã¥¯¥¹¡¦¥¹¥¿¥ó¥À¡¼¥É100¤Ë²Ã¤¨¡¢¤µ¤é¤ËÊñ³çŪ¤Ê»ëÅÀ¤ÇÁ¡°ÝÀ½ÉʤòÀ¸»º¤¹¤ë¹©¾ì¤ä ´ë¶È¤¬¤¤¤«¤Ë»ý³²Äǽ¤ÊÂÎÀ©¤Ç¤¢¤ë¤«¤òɾ²Á¤¹¤ë¡Ö¥¨¥³¥Æ¥Ã¥¯¥¹STeP¡×ǧ¾Ú¤â³ÍÆÀ¤·¤Æ¤¤¤Þ¤¹¡£ ¤´Ãí°Õ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¼Àɤμ£Ìþ¤äͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¤¹¤Ù¤Æ¤Îɸ¶¶Ý¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ¡¦·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¹¡£¼ÂºÝ¤Î»ÈÍѴĶ¤Ë¤ª¤¤¤ÆƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ M.J. (2020) Report on "Viral Stability and Persistence of SARS-CoV-2 on Treated Material".Doherty Institute for Infection and Immunity, Australia¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤Ï¤¹¤Ù¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¢¨ ²èÁü¤Ï¥¤¥á¡¼¥¸¤Ç¤¹¡£¥â¥Ë¥¿¡¼¤Ë¤è¤ê¼ÂºÝ¤Î¿§Ì£¤È¿¾¯°Û¤Ê¤ë¾ì¹ç¤¬¤´¤¶¤¤¤Þ¤¹¡£
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í ¥Ö¥í¥Ã¥¯¡¦¥·¥ê¡¼¥º¤ò¿ä¾©¤¹¤ëÍýͳ¤Ï¡¢¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤¬Èó¾ï¤ËÌÌÇò¤¤ÆÃħ¤òÈ÷¤¨¤Æ¤¤¤ë¤«¤é¤Ç¤¹¡£¤³¤ì¤Ï¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¼Ò¤È¥Ï¥¤¥¥å¼Ò¤¬¹çƱ¤Ç³«È¯¤·¤¿¤â¤Î¤Ç¡¢¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ê¤Î¤Ç¤¹¤¬¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»¤ÆÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢Èó¾ï¤Ë¶¯¤¤¹³ÈùÀ¸ÊªºîÍÑ¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤È¤¤¤¦¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤½¤Î͸úÀ¤Ë´Ø¤·¤Þ¤·¤Æ¤Ï¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤Î¥É¥Ï¡¼¥Æ¥£¡¼¸¦µæ½ê¤È¤¤¤¦¸¢°Ò¤¢¤ë¸¦µæ½ê¤Ë¤ª¤¤¤Æ¡¢¤·¤«¤â¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤òÍѤ¤¤¿¼Â¾Ú¼Â¸³¤ò¹Ô¤¤¡¢30ʬ´Ö¤Ç99.99%¤Î¥¦¥¤¥ë¥¹¤òÉԳ貽¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤³¤Î¥·¥ê¡¼¥º¤Ë¤è¤Ã¤Æ¥¦¥¤¥ë¥¹¤ò¿²¼¼¤Ç¥·¥ã¥Ã¥È¥¢¥¦¥È¤Ç¤¤ë¤È¤¹¤ì¤Ð¡¢¤ªÇ¯´ó¤ê¤äÀÖ¤Á¤ã¤ó¡¢¤½¤·¤Æ½Å¾É²½¥ê¥¹¥¯¤¬¹â¤¤¤È¤¤¤ï¤ì¤ë´ðÁüÀ´µ¤ò¤ª»ý¤Á¤ÎÊý¤Ë¤È¤Ã¤Æ²¿¤è¤êϯÊó¤È¤Ê¤ë¤â¤Î¤È¹Í¤¨¤Þ¤¹¡£¿Í´Ö¤Ï½¢¿²»þ¤Ë´À¤ò¤«¤¯¤¿¤á¡¢¤½¤â¤½¤â¿²¶ñ¤Ïɸ¶ÂΤ¬À¸Â©¤·ÈË¿£¤·¤ä¤¹¤¤´Ä¶¤Ë¤¢¤ê¤Þ¤¹¡£¥¦¥¤¥ë¥¹Âкö¤È¤·¤Æ¤â͸úÀ¤¬³Îǧ¤µ¤ì¤Æ¤¤¤ë¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤Ï¡¢Ä󾧤µ¤ì¤ë¿·¤·¤¤À¸³èÍͼ°¤Ë¤ª¤¤¤Æ½ÅÍפÊÌò³ä¤òô¤¦¥¢¥¤¥Æ¥à¤Î°ì¤Ä¤È¤Ê¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£ ¹³¶Ý¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©À¸ÃϤò»ÈÍѤ·¤Æ¤¤¤Þ¤¹¡£¥Þ¥Ã¥È¥ì¥¹¤ä»°¤ÄÀÞ¤ê¥Þ¥Ã¥È¥ì¥¹¡¢¥Õ¥È¥ó¥¿¥¤¥×¤ÈÉý¹¤¤ÍÑÅӤˤ´»ÈÍÑ失¤Þ¤¹¡£¤ªÀöÂõ¤Ç¤°Â¿´¤·¤Æ¤ª»È¤¤Äº¤±¤Þ¤¹¡£(¹³¥¦¥¤¥ë¥¹¸ú²Ì¤ÏÀöÂõ30²ó¤Þ¤Ç¸ú²Ì¤¬»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£) ¢¨¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤ÏÁ´¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£ ¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¾¦ÉÊ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ VIROBLOCK ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º ¥·¥ó¥°¥ëÉý100 ¡ß ±ü¹Ô195 ¡ß ¸ü¤µ11?27cm ÁÈÀ® ¥Ý¥ê¥¨¥¹¥Æ¥ë 100¡ó¡ãHeiQ Viroblock²Ã¹©¡ä ÇÛ¿§ ¥Û¥ï¥¤¥È ÀöÂõ ¿åÀö¤¤OK¡ª ¤´¼«Âð¤ÇÀöÂõ¤¬¤Ç¤¤Þ¤¹ ¢¨ÀöÂõµ¡¤ÎÍÆÎ̤ò¤´³Îǧ¤¯¤À¤µ¤¤ ¢¨ÁªÂò¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í ¥Ö¥í¥Ã¥¯¡¦¥·¥ê¡¼¥º¤ò¿ä¾©¤¹¤ëÍýͳ¤Ï¡¢¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤¬Èó¾ï¤ËÌÌÇò¤¤ÆÃħ¤òÈ÷¤¨¤Æ¤¤¤ë¤«¤é¤Ç¤¹¡£¤³¤ì¤Ï¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¼Ò¤È¥Ï¥¤¥¥å¼Ò¤¬¹çƱ¤Ç³«È¯¤·¤¿¤â¤Î¤Ç¡¢¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ê¤Î¤Ç¤¹¤¬¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»¤ÆÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢Èó¾ï¤Ë¶¯¤¤¹³ÈùÀ¸ÊªºîÍÑ¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤È¤¤¤¦¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤½¤Î͸úÀ¤Ë´Ø¤·¤Þ¤·¤Æ¤Ï¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤Î¥É¥Ï¡¼¥Æ¥£¡¼¸¦µæ½ê¤È¤¤¤¦¸¢°Ò¤¢¤ë¸¦µæ½ê¤Ë¤ª¤¤¤Æ¡¢¤·¤«¤â¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤òÍѤ¤¤¿¼Â¾Ú¼Â¸³¤ò¹Ô¤¤¡¢30ʬ´Ö¤Ç99.99%¤Î¥¦¥¤¥ë¥¹¤òÉԳ貽¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤³¤Î¥·¥ê¡¼¥º¤Ë¤è¤Ã¤Æ¥¦¥¤¥ë¥¹¤ò¿²¼¼¤Ç¥·¥ã¥Ã¥È¥¢¥¦¥È¤Ç¤¤ë¤È¤¹¤ì¤Ð¡¢¤ªÇ¯´ó¤ê¤äÀÖ¤Á¤ã¤ó¡¢¤½¤·¤Æ½Å¾É²½¥ê¥¹¥¯¤¬¹â¤¤¤È¤¤¤ï¤ì¤ë´ðÁüÀ´µ¤ò¤ª»ý¤Á¤ÎÊý¤Ë¤È¤Ã¤Æ²¿¤è¤êϯÊó¤È¤Ê¤ë¤â¤Î¤È¹Í¤¨¤Þ¤¹¡£¿Í´Ö¤Ï½¢¿²»þ¤Ë´À¤ò¤«¤¯¤¿¤á¡¢¤½¤â¤½¤â¿²¶ñ¤Ïɸ¶ÂΤ¬À¸Â©¤·ÈË¿£¤·¤ä¤¹¤¤´Ä¶¤Ë¤¢¤ê¤Þ¤¹¡£¥¦¥¤¥ë¥¹Âкö¤È¤·¤Æ¤â͸úÀ¤¬³Îǧ¤µ¤ì¤Æ¤¤¤ë¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤Ï¡¢Ä󾧤µ¤ì¤ë¿·¤·¤¤À¸³èÍͼ°¤Ë¤ª¤¤¤Æ½ÅÍפÊÌò³ä¤òô¤¦¥¢¥¤¥Æ¥à¤Î°ì¤Ä¤È¤Ê¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£ ¹³¶Ý¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©À¸ÃϤò»ÈÍѤ·¤Æ¤¤¤Þ¤¹¡£¥Þ¥Ã¥È¥ì¥¹¤ä»°¤ÄÀÞ¤ê¥Þ¥Ã¥È¥ì¥¹¡¢¥Õ¥È¥ó¥¿¥¤¥×¤ÈÉý¹¤¤ÍÑÅӤˤ´»ÈÍÑ失¤Þ¤¹¡£¤ªÀöÂõ¤Ç¤°Â¿´¤·¤Æ¤ª»È¤¤Äº¤±¤Þ¤¹¡£(¹³¥¦¥¤¥ë¥¹¸ú²Ì¤ÏÀöÂõ30²ó¤Þ¤Ç¸ú²Ì¤¬»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£) ¢¨¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤ÏÁ´¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£ ¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¾¦ÉÊ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ VIROBLOCK ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º ¥»¥ß¥À¥Ö¥ëÉý120 ¡ß ±ü¹Ô195 ¡ß ¸ü¤µ11?27cm ÁÈÀ® ¥Ý¥ê¥¨¥¹¥Æ¥ë 100¡ó¡ãHeiQ Viroblock²Ã¹©¡ä ÇÛ¿§ ¥Û¥ï¥¤¥È ÀöÂõ ¿åÀö¤¤OK¡ª ¤´¼«Âð¤ÇÀöÂõ¤¬¤Ç¤¤Þ¤¹ ¢¨ÀöÂõµ¡¤ÎÍÆÎ̤ò¤´³Îǧ¤¯¤À¤µ¤¤ ¢¨ÁªÂò¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í ¥Ö¥í¥Ã¥¯¡¦¥·¥ê¡¼¥º¤ò¿ä¾©¤¹¤ëÍýͳ¤Ï¡¢¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤¬Èó¾ï¤ËÌÌÇò¤¤ÆÃħ¤òÈ÷¤¨¤Æ¤¤¤ë¤«¤é¤Ç¤¹¡£¤³¤ì¤Ï¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¼Ò¤È¥Ï¥¤¥¥å¼Ò¤¬¹çƱ¤Ç³«È¯¤·¤¿¤â¤Î¤Ç¡¢¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ê¤Î¤Ç¤¹¤¬¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»¤ÆÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢Èó¾ï¤Ë¶¯¤¤¹³ÈùÀ¸ÊªºîÍÑ¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤È¤¤¤¦¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤½¤Î͸úÀ¤Ë´Ø¤·¤Þ¤·¤Æ¤Ï¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤Î¥É¥Ï¡¼¥Æ¥£¡¼¸¦µæ½ê¤È¤¤¤¦¸¢°Ò¤¢¤ë¸¦µæ½ê¤Ë¤ª¤¤¤Æ¡¢¤·¤«¤â¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤òÍѤ¤¤¿¼Â¾Ú¼Â¸³¤ò¹Ô¤¤¡¢30ʬ´Ö¤Ç99.99%¤Î¥¦¥¤¥ë¥¹¤òÉԳ貽¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤³¤Î¥·¥ê¡¼¥º¤Ë¤è¤Ã¤Æ¥¦¥¤¥ë¥¹¤ò¿²¼¼¤Ç¥·¥ã¥Ã¥È¥¢¥¦¥È¤Ç¤¤ë¤È¤¹¤ì¤Ð¡¢¤ªÇ¯´ó¤ê¤äÀÖ¤Á¤ã¤ó¡¢¤½¤·¤Æ½Å¾É²½¥ê¥¹¥¯¤¬¹â¤¤¤È¤¤¤ï¤ì¤ë´ðÁüÀ´µ¤ò¤ª»ý¤Á¤ÎÊý¤Ë¤È¤Ã¤Æ²¿¤è¤êϯÊó¤È¤Ê¤ë¤â¤Î¤È¹Í¤¨¤Þ¤¹¡£¿Í´Ö¤Ï½¢¿²»þ¤Ë´À¤ò¤«¤¯¤¿¤á¡¢¤½¤â¤½¤â¿²¶ñ¤Ïɸ¶ÂΤ¬À¸Â©¤·ÈË¿£¤·¤ä¤¹¤¤´Ä¶¤Ë¤¢¤ê¤Þ¤¹¡£¥¦¥¤¥ë¥¹Âкö¤È¤·¤Æ¤â͸úÀ¤¬³Îǧ¤µ¤ì¤Æ¤¤¤ë¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤Ï¡¢Ä󾧤µ¤ì¤ë¿·¤·¤¤À¸³èÍͼ°¤Ë¤ª¤¤¤Æ½ÅÍפÊÌò³ä¤òô¤¦¥¢¥¤¥Æ¥à¤Î°ì¤Ä¤È¤Ê¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£ ¹³¶Ý¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©À¸ÃϤò»ÈÍѤ·¤Æ¤¤¤Þ¤¹¡£¥Þ¥Ã¥È¥ì¥¹¤ä»°¤ÄÀÞ¤ê¥Þ¥Ã¥È¥ì¥¹¡¢¥Õ¥È¥ó¥¿¥¤¥×¤ÈÉý¹¤¤ÍÑÅӤˤ´»ÈÍÑ失¤Þ¤¹¡£¤ªÀöÂõ¤Ç¤°Â¿´¤·¤Æ¤ª»È¤¤Äº¤±¤Þ¤¹¡£(¹³¥¦¥¤¥ë¥¹¸ú²Ì¤ÏÀöÂõ30²ó¤Þ¤Ç¸ú²Ì¤¬»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£) ¢¨¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤ÏÁ´¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£ ¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¾¦ÉÊ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ VIROBLOCK ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º ¥À¥Ö¥ëÉý140 ¡ß ±ü¹Ô195 ¡ß ¸ü¤µ11?27cm ÁÈÀ® ¥Ý¥ê¥¨¥¹¥Æ¥ë 100¡ó¡ãHeiQ Viroblock²Ã¹©¡ä ÇÛ¿§ ¥Û¥ï¥¤¥È ÀöÂõ ¿åÀö¤¤OK¡ª ¤´¼«Âð¤ÇÀöÂõ¤¬¤Ç¤¤Þ¤¹ ¢¨ÀöÂõµ¡¤ÎÍÆÎ̤ò¤´³Îǧ¤¯¤À¤µ¤¤ ¢¨ÁªÂò¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í ¥Ö¥í¥Ã¥¯¡¦¥·¥ê¡¼¥º¤ò¿ä¾©¤¹¤ëÍýͳ¤Ï¡¢¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤¬Èó¾ï¤ËÌÌÇò¤¤ÆÃħ¤òÈ÷¤¨¤Æ¤¤¤ë¤«¤é¤Ç¤¹¡£¤³¤ì¤Ï¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¼Ò¤È¥Ï¥¤¥¥å¼Ò¤¬¹çƱ¤Ç³«È¯¤·¤¿¤â¤Î¤Ç¡¢¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ê¤Î¤Ç¤¹¤¬¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»¤ÆÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢Èó¾ï¤Ë¶¯¤¤¹³ÈùÀ¸ÊªºîÍÑ¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤È¤¤¤¦¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤½¤Î͸úÀ¤Ë´Ø¤·¤Þ¤·¤Æ¤Ï¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤Î¥É¥Ï¡¼¥Æ¥£¡¼¸¦µæ½ê¤È¤¤¤¦¸¢°Ò¤¢¤ë¸¦µæ½ê¤Ë¤ª¤¤¤Æ¡¢¤·¤«¤â¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤òÍѤ¤¤¿¼Â¾Ú¼Â¸³¤ò¹Ô¤¤¡¢30ʬ´Ö¤Ç99.99%¤Î¥¦¥¤¥ë¥¹¤òÉԳ貽¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤³¤Î¥·¥ê¡¼¥º¤Ë¤è¤Ã¤Æ¥¦¥¤¥ë¥¹¤ò¿²¼¼¤Ç¥·¥ã¥Ã¥È¥¢¥¦¥È¤Ç¤¤ë¤È¤¹¤ì¤Ð¡¢¤ªÇ¯´ó¤ê¤äÀÖ¤Á¤ã¤ó¡¢¤½¤·¤Æ½Å¾É²½¥ê¥¹¥¯¤¬¹â¤¤¤È¤¤¤ï¤ì¤ë´ðÁüÀ´µ¤ò¤ª»ý¤Á¤ÎÊý¤Ë¤È¤Ã¤Æ²¿¤è¤êϯÊó¤È¤Ê¤ë¤â¤Î¤È¹Í¤¨¤Þ¤¹¡£¿Í´Ö¤Ï½¢¿²»þ¤Ë´À¤ò¤«¤¯¤¿¤á¡¢¤½¤â¤½¤â¿²¶ñ¤Ïɸ¶ÂΤ¬À¸Â©¤·ÈË¿£¤·¤ä¤¹¤¤´Ä¶¤Ë¤¢¤ê¤Þ¤¹¡£¥¦¥¤¥ë¥¹Âкö¤È¤·¤Æ¤â͸úÀ¤¬³Îǧ¤µ¤ì¤Æ¤¤¤ë¤³¤Î¿²¶ñ¥·¥ê¡¼¥º¤Ï¡¢Ä󾧤µ¤ì¤ë¿·¤·¤¤À¸³èÍͼ°¤Ë¤ª¤¤¤Æ½ÅÍפÊÌò³ä¤òô¤¦¥¢¥¤¥Æ¥à¤Î°ì¤Ä¤È¤Ê¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£ ¹³¶Ý¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©À¸ÃϤò»ÈÍѤ·¤Æ¤¤¤Þ¤¹¡£¥Þ¥Ã¥È¥ì¥¹¤ä»°¤ÄÀÞ¤ê¥Þ¥Ã¥È¥ì¥¹¡¢¥Õ¥È¥ó¥¿¥¤¥×¤ÈÉý¹¤¤ÍÑÅӤˤ´»ÈÍÑ失¤Þ¤¹¡£¤ªÀöÂõ¤Ç¤°Â¿´¤·¤Æ¤ª»È¤¤Äº¤±¤Þ¤¹¡£(¹³¥¦¥¤¥ë¥¹¸ú²Ì¤ÏÀöÂõ30²ó¤Þ¤Ç¸ú²Ì¤¬»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£) ¢¨¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤ÏÁ´¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£ ¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¾¦ÉÊ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ VIROBLOCK ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º ¥¯¥¤¡¼¥óÉý160 ¡ß ±ü¹Ô195 ¡ß ¸ü¤µ11?27cm ÁÈÀ® ¥Ý¥ê¥¨¥¹¥Æ¥ë 100¡ó¡ãHeiQ Viroblock²Ã¹©¡ä ÇÛ¿§ ¥Û¥ï¥¤¥È ÀöÂõ ¿åÀö¤¤OK¡ª ¤´¼«Âð¤ÇÀöÂõ¤¬¤Ç¤¤Þ¤¹ ¢¨ÀöÂõµ¡¤ÎÍÆÎ̤ò¤´³Îǧ¤¯¤À¤µ¤¤ ¢¨ÁªÂò¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º W120¡ßD195¡ßH11¡Á27cmÍÑ ¡Ê¥»¥ß¥À¥Ö¥ë¥µ¥¤¥º¡Ë¡¡ ¦À¸ÃÏ ¥Ý¥ê¥¨¥¹¥Æ¥ë100¡ó ¤ª¼êÆþ¤ì ¿åÀö¤¤²Äǽ ¢¨ÀöÂõ¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤¡£ ¢¨¥¿¥ó¥Ö¥é¡¼´¥Áç¤Ï¤ªÈò¤±¤¯¤À¤µ¤¤¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥¤¥¿¥ê¥¢È¯¤Î¿²¶ñÁí¹ç¥Ö¥é¥ó¥É¡Ö¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡× ¿²¼¼¤òÂ礤ʰ¿´¤ÇÊñ¤à ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥·¥ê¡¼¥º ¥¹¥¤¥¹¡¦¥Ï¥¤¥¥å¼Ò¤ÎÀèü¥Æ¥¯¥Î¥í¥¸¡¼¤òƳÆþ¤¹¤ë¤³¤È¤ÇÈó¾ï¤ËÍ¥¤ì¤¿¹³¶Ý¸ú²Ì¤ò¼Â¸½ ¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¡¢¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ç¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»ÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ Èó¾ï¤ËÍ¥¤ì¤¿¹³ÈùÀ¸Êª¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ ¦À¸ÃϤϼè¤ê³°¤·¤Æ¤ªÀöÂõ¤¬²Äǽ¤Ç¡¢HEIQ VIROBLOCKµ»½Ñ¤ò¹½À®¤¹¤ë2¤Ä¤Îµ»½Ñ¤Î¤¦¤Á¶äÀ®Ê¬¤Ï60¡î¤Î¤Ì¤ë¤ÞÅò¤Ç 50²ó¡¢¥Ù¥·¥¯¥ëµ»½Ñ¤Ï30²ó¤Î¤ªÀöÂõ¤Ç¸ú²Ì¤ò»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ 60¡î¡Á70¡îÄøÅ٤Υ¢¥¤¥í¥ó¤â²Ã¹©¤Ë±Æ¶Á¤òµÚ¤Ü¤¹¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹À½Éʤˤª¤¤¤Æ¿ÍÂΡ¢Ãϵå´Ä¶¤Ë°ìÀÚ̵³²¤Ç¤¢¤ë¤³¤È¤òǧÄꤹ¤ë¹ñºÝµ¬³Ê¡ÖOEKO-TEX¥¹¥¿¥ó¥À¡¼¥É100¡×¤ò¼èÆÀ °ÂÁ´¤ÊÁ¡°ÝÀ½ÉʤǤ¢¤ë¾Ú¥¨¥³¥Æ¥Ã¥¯¥¹¡¦¥¹¥¿¥ó¥À¡¼¥É100¤Ë²Ã¤¨¡¢¤µ¤é¤ËÊñ³çŪ¤Ê»ëÅÀ¤ÇÁ¡°ÝÀ½ÉʤòÀ¸»º¤¹¤ë¹©¾ì¤ä ´ë¶È¤¬¤¤¤«¤Ë»ý³²Äǽ¤ÊÂÎÀ©¤Ç¤¢¤ë¤«¤òɾ²Á¤¹¤ë¡Ö¥¨¥³¥Æ¥Ã¥¯¥¹STeP¡×ǧ¾Ú¤â³ÍÆÀ¤·¤Æ¤¤¤Þ¤¹¡£ ¤´Ãí°Õ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¼Àɤμ£Ìþ¤äͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¤¹¤Ù¤Æ¤Îɸ¶¶Ý¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ¡¦·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¹¡£¼ÂºÝ¤Î»ÈÍѴĶ¤Ë¤ª¤¤¤ÆƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ M.J. (2020) Report on "Viral Stability and Persistence of SARS-CoV-2 on Treated Material".Doherty Institute for Infection and Immunity, Australia¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤Ï¤¹¤Ù¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¢¨ ²èÁü¤Ï¥¤¥á¡¼¥¸¤Ç¤¹¡£¥â¥Ë¥¿¡¼¤Ë¤è¤ê¼ÂºÝ¤Î¿§Ì£¤È¿¾¯°Û¤Ê¤ë¾ì¹ç¤¬¤´¤¶¤¤¤Þ¤¹¡£
¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥µ¥¤¥º W100¡ßD195¡ßH11¡Á27cmÍÑ ¡Ê¥·¥ó¥°¥ë¥µ¥¤¥º¡Ë¡¡ ¦À¸ÃÏ ¥Ý¥ê¥¨¥¹¥Æ¥ë100¡ó ¤ª¼êÆþ¤ì ¿åÀö¤¤²Äǽ ¢¨ÀöÂõ¥Í¥Ã¥È¤ò¤´»ÈÍѤ¯¤À¤µ¤¤¡£ ¢¨¥¿¥ó¥Ö¥é¡¼´¥Áç¤Ï¤ªÈò¤±¤¯¤À¤µ¤¤¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹ ¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥Ü¥Ã¥¯¥¹¥·¡¼¥Ä ¥¤¥¿¥ê¥¢È¯¤Î¿²¶ñÁí¹ç¥Ö¥é¥ó¥É¡Ö¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡× ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹¡ß¥Ï¥¤¥¥å ¥ô¥£¥í¥Ö¥í¥Ã¥¯ ¥·¥ê¡¼¥º ¥¹¥¤¥¹¡¦¥Ï¥¤¥¥å¼Ò¤ÎÀèü¥Æ¥¯¥Î¥í¥¸¡¼¤òƳÆþ¤¹¤ë¤³¤È¤ÇÈó¾ï¤ËÍ¥¤ì¤¿¹³¶Ý¸ú²Ì¤ò¼Â¸½ ¥ô¥£¥í¥Ö¥í¥Ã¥¯¤È¤Ï¡¢¥¦¥¤¥ë¥¹¥Ö¥í¥Ã¥¯¤È¤¤¤¦°ÕÌ£¤Ç¡¢Á¡°Ý¤ÎÃæ¤Ë¶ä¤ò¤·¤Ã¤«¤êÀ÷¤ß¹þ¤Þ¤»ÄêÃ夵¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ Èó¾ï¤ËÍ¥¤ì¤¿¹³ÈùÀ¸Êª¡¢¹³¥¦¥¤¥ë¥¹ºîÍѤòȯ´ø¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ ¦À¸ÃϤϼè¤ê³°¤·¤Æ¤ªÀöÂõ¤¬²Äǽ¤Ç¡¢HEIQ VIROBLOCKµ»½Ñ¤ò¹½À®¤¹¤ë2¤Ä¤Îµ»½Ñ¤Î¤¦¤Á¶äÀ®Ê¬¤Ï60¡î¤Î¤Ì¤ë¤ÞÅò¤Ç 50²ó¡¢¥Ù¥·¥¯¥ëµ»½Ñ¤Ï30²ó¤Î¤ªÀöÂõ¤Ç¸ú²Ì¤ò»ý³¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ 60¡î¡Á70¡îÄøÅ٤Υ¢¥¤¥í¥ó¤â²Ã¹©¤Ë±Æ¶Á¤òµÚ¤Ü¤¹¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¥Þ¥Ë¥Õ¥ì¥Ã¥¯¥¹À½Éʤˤª¤¤¤Æ¿ÍÂΡ¢Ãϵå´Ä¶¤Ë°ìÀÚ̵³²¤Ç¤¢¤ë¤³¤È¤òǧÄꤹ¤ë¹ñºÝµ¬³Ê¡ÖOEKO-TEX¥¹¥¿¥ó¥À¡¼¥É100¡×¤ò¼èÆÀ °ÂÁ´¤ÊÁ¡°ÝÀ½ÉʤǤ¢¤ë¾Ú¥¨¥³¥Æ¥Ã¥¯¥¹¡¦¥¹¥¿¥ó¥À¡¼¥É100¤Ë²Ã¤¨¡¢¤µ¤é¤ËÊñ³çŪ¤Ê»ëÅÀ¤ÇÁ¡°ÝÀ½ÉʤòÀ¸»º¤¹¤ë¹©¾ì¤ä ´ë¶È¤¬¤¤¤«¤Ë»ý³²Äǽ¤ÊÂÎÀ©¤Ç¤¢¤ë¤«¤òɾ²Á¤¹¤ë¡Ö¥¨¥³¥Æ¥Ã¥¯¥¹STeP¡×ǧ¾Ú¤â³ÍÆÀ¤·¤Æ¤¤¤Þ¤¹¡£ ¤´Ãí°Õ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¼Àɤμ£Ìþ¤äͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¡¦¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ï¤¹¤Ù¤Æ¤Îɸ¶¶Ý¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ¡¦·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¹¡£¼ÂºÝ¤Î»ÈÍѴĶ¤Ë¤ª¤¤¤ÆƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ M.J. (2020) Report on "Viral Stability and Persistence of SARS-CoV-2 on Treated Material".Doherty Institute for Infection and Immunity, Australia¤´Ãí°Õ ¹³¥¦¥¤¥ë¥¹²Ã¹©¤Ïɵ¤¤Î¼£ÎŤäͽËɤòÌÜŪ¤È¤¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ËÜÀ½Éʤϴ¶À÷ͽËɤòÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹³¥¦¥¤¥ë¥¹Àǽ¤Ï¤¹¤Ù¤Æ¤Î¥¦¥¤¥ë¥¹¤ËÂФ·¤Æȯ¸½¤¹¤ë¤â¤Î¤Ç¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£ ·ÇºÜ¥Ç¡¼¥¿¤Ï»î¸³·ë²Ì¤Ç¤¢¤êÊݾÚÃͤǤϤ¢¤ê¤Þ¤»¤ó¡£¤Þ¤¿¼ÂºÝ¤Î»ÈÍѾõ¶·¤ÇƱÍͤθú²Ì¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¢¨ ²èÁü¤Ï¥¤¥á¡¼¥¸¤Ç¤¹¡£¥â¥Ë¥¿¡¼¤Ë¤è¤ê¼ÂºÝ¤Î¿§Ì£¤È¿¾¯°Û¤Ê¤ë¾ì¹ç¤¬¤´¤¶¤¤¤Þ¤¹¡£